Harrow Raises $50M via Senior Notes as Ophthalmic Firm Funds Growth
Harrow prices $50M in senior unsecured notes due 2030, expanding existing debt facility for product development and strategic initiatives.
HROWproduct developmentcapital raise


Investing.com··Sam Quirke



Investing.com··Dan Schmidt

